Charles Schwab
RPID icon

Charles Schwab’s Rapid Micro Biosystems RPID Stock Holding History

Charles Schwab’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-35,478
Closed -$241K – 3628
2022
Q1 		$241K Buy
35,478
+14,059
+66% +$104K ﹤0.01% 3273
2021
Q4 		$228K Buy
21,419
+1,640
+8% +$25.6K ﹤0.01% 3341
2021
Q3 		$366K Buy
+19,779
New +$409K ﹤0.01% 3221

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
KLM
Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Charles Schwab's RPID Position: Q2 2022 in Review

Charles Schwab sold out of Rapid Micro Biosystems (RPID) in Q2 2022, closing a stake of 35,478 shares — an estimated $241K sold.

Charles Schwab first reported a position in RPID in Q3 2021 and held it in 3 quarters. The position peaked at $366K in Q3 2021. 52 funds tracked by Wall St. Rank hold RPID as of Q2 2022.

  • Charles Schwab reported no remaining Rapid Micro Biosystems position as of Q2 2022 after selling out during the quarter.
  • Charles Schwab sold 35,478 Rapid Micro Biosystems shares in Q2 2022, an estimated $241K.
  • Charles Schwab first reported a position in Rapid Micro Biosystems in Q3 2021 and held it in 3 quarters.
  • Charles Schwab's Rapid Micro Biosystems position peaked at $366K in Q3 2021.
  • 52 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q2 2022.

Based on Charles Schwab's 13F filing for Q2 2022, filed 15 Aug 2022.